The evaluation of Tenecteplase for the treatment of ischemic stroke (real-world data)

ImportanceThe study reinforces the use of Tenecteplase (TNK) dosed at 0.25 mg/kg in real-world community settings as an effective and safe alternative to alteplase standard dosing.ObjectiveThe aim of this study is to evaluate the effectiveness and safety of TNK compared to alteplase in a community h...

Descripció completa

Dades bibliogràfiques

Autors principals:	William Braun, Allan Weiss, Harold Colbassani, Ajay Arora, Paul Lewis, Eric Lopez del Valle, Marissa Lepain, Christi Newman, Keith Chastain
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-07-01
Col·lecció:	Frontiers in Neurology
Matèries:	ischemic stroke large vessel occlusion modified Rankin scale Tenecteplase thrombectomy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fneur.2026.1869006/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!